Zdrowie i gospodarka · 22/02/2011
FDA Clears Theophylline Oral Solution for Approval
The FDA has determined that theophylline oral solution, 80 mg/15 mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.
Source: Federal Register — Health and Human ServicesOpen original release →